intranasal glutathione in parkinson's disease Research progress on treatment for - Wen - 2024 - Neuroprotection Intranasal Delivery of Metabolically Resilient
Intranasal Delivery of Metabolically Resilient Glutathione: In Vivo Pharmacokinetic, Permeation, and Efficacy Studies Molecular Pharmaceutics Glutathione IV Therapy The Parkinson's Plan Potential use of glutathione as a treatment for Parkinson's disease PMC Revolutionizing Parkinson's treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy Drug Delivery and Translational Research Springer Nature Link Pharmacokinetics and pharmacodynamics of intranasally administered selegiline nanoparticles with improved brain delivery in Parkinson's disease ScienceDirect
Pay in 4 interest-free payments of $7.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




